Benhamou 2007.

Study characteristics
Methods	One‐year efficacy and safety of web‐based follow‐up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study Cross‐over RCT, conducted in diabetology clinic outpatients at a clinic from Grenoble and Toulouse, France Two arms: 1) No‐SMS (control arm) and 2) SMS (intervention arm)
Participants	Control arm N: 15 Intervention arm N: 15 Diabetes type: type I Mean age: 41.3 ± 11.3 % Male: 50.0 Longest follow‐up: 6 months
Interventions	Control arm: None Intervention arm: 1) Electronic patient registry 2) Facilitated relay of clinical information 3) Promotion of self‐management
Outcomes	1) Glycated haemoglobin 2) Harms (severe hypoglycaemia or diabetic ketoacidosis)
Funding source	This study was supported by research grants from Direction de la Recherche Clinique, CHU Grenoble and from Agir‐aDom. Material was provided by Roche Diagnostics France and by Palm Inc. France
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Random sequence generation (selection bias)	Unclear risk	Information not available.
Allocation concealment (selection bias)	Unclear risk	Information not available.
Patient's baseline characteristics (selection bias)	Low risk	Information not available.
Patient's baseline outcomes (selection bias)	Low risk	Information not available.
Incomplete outcome data (attrition bias)	Unclear risk	Do not report numbers of dropouts by group.
Blinding of participants and personnel (performance bias) and of outcome assessors (detection bias)	Low risk	Information not available.
Selective reporting (reporting bias)	Low risk	Information not available.
Risk of contamination (other bias)	Low risk	Information not available.
Other bias	Unclear risk	Information not available.